Ecto-ADP-ribose transferases: Cell-surface response to local tissue injury

Physiology

Volumn 20, Issue 6, 2005, Pages 374-381

  Zolkiewska, Anna ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL; CELL MEMBRANE; ENZYMOLOGY; GENERAL ASPECTS OF DISEASE; HUMAN; INJURY; METABOLISM; REVIEW;

ADP RIBOSE TRANSFERASES; ANIMALS; CELL MEMBRANE; DISEASE; HUMANS; WOUNDS AND INJURIES;

EID: 29144526631     PISSN: 15489213     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiol.00028.2005     Document Type: Review

References (106)

1. Ablamunits V, Bridgett M, Duffy T, Haag F, Nissen M, Koch-Nolte F, and Leiter H. Changing patterns of cell surface mono (ADP-ribosyl) transferase antigen ART2.2 on resting versus cytopathically-activated T cells in NOD/Lt mice. Diabetologia 44: 848-858, 2001.
2. Accili D and Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117: 421-426, 2004.
3. Adriouch S, Ohlrogge W, Haag F, Koch-Nolte F, and Seman M. Rapid induction of naive T cell apoptosis by ecto-nicotinamide adenine dinucleotide: requirement for mono(ADP-ribosyl)transferase 2 and a downstream effector. J Immunol 167: 196-203, 2001.
4. Aktories K. Rho proteins: targets for bacterial toxins. Trends Microbiol 5: 282-288, 1997.
5. Ame JC, Spenlehauer C, and de Murcia G. The PARP superfamily. Bioessays 26: 882-893, 2004.
6. Bansal D and Campbell KP. Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol 14: 206-213, 2004.
7. 1 integrin epitope induced by soluble ligand and manganese, but inhibited by calcium. J Biol Chem 270: 25570-25577, 1995.
8. 1 integrins. Biochim Biophys Acta 1663: 52-60, 2004.
9. Berger F, Ramirez-Hernandez MH, and Ziegler M. The new life of a centenarian: signalling functions of NAD(P). Trends Biochem Sci 29: 111-118, 2004.
10. 1 integrin signals secondary myofiber formation. Dev Biol 233:148-160, 2001.
11. Blander G and Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem 73: 417-435, 2004.
12. Bordone L and Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 6: 298-305, 2005.
13. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, and Greenberg ME. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015, 2004.
14. + fluxes in intact cells. FASEB J 15: 10-12, 2001.
15. Burkholder TJ. Permeability of C2C12 myotube membranes is influenced by stretch velocity. Biochem Biophys Res Commun 305: 266-270, 2003.
16. 1 integrin in muscle development and disease. Cell Tissue Res 296: 183-190, 1999.
17. 1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice. Am J Pathol 166: 253-263, 2005.
18. 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J Cell Biol 152: 1207-1218, 2001.
19. Burkle A, Beneke S, and Muiras ML. Poly(ADP-ribosyl)ation and aging. Exp Gerontol 39: 1599-1601, 2004.
20. Clarke MS, Caldwell RW, Chiao H, Miyake K, and McNeil PL. Contraction-induced cell wounding and release of fibroblast growth factor in heart. Circ Res 76: 927-934, 1995.
21. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, and Sinclair DA. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305: 390-392, 2004.
22. Contreras JE, Saez JC, Bukauskas FF, and Bennett MV. Gating and regulation of connexin 43 (Cx43) hemichannels. Proc Natl Acad Sci USA 100: 11388-11393, 2003.
23. Contreras JE, Sanchez HA, Eugenin EA, Speidel D, Theis M, Willecke K, Bukauskas FF, Bennett MV, and Saez JC. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc Natl Acad Sci USA 99: 495-500, 2002.
24. Corda D and Di Girolamo M. Functional aspects of protein mono-ADP-ribosylation. EMBO J 22: 1953-1958, 2003.
25. Doherty KR and McNally EM. Repairing the tears: dysferlin in muscle membrane repair. Trends Mol Med 9: 327-330, 2003.
26. Donnelly LE, Rendell NB, Murray S, Allport JR, Lo G, Kefalas P, Taylor GW, and MacDermot J. Arginine-specific mono(ADP-ribosyl)transferase activity on the surface of human polymorphonuclear neutrophil leucocytes. Biochem J 315: 635-641, 1996.
27. Ervasti JM and Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122: 809-823, 1993.
28. Fulco M, Schiltz RL, Iezzi S, King MT, Zhao P, Kashiwaya Y, Hoffman E, Veech RL, and Sartorelli V. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell 12: 51-62, 2003.
29. Geddes DM, Cargill RS 2nd, and LaPlaca MC. Mechanical stretch to neurons results in a strain rate and magnitude-dependent increase in plasma membrane permeability. J Neurotrauma 20: 1039-1049, 2003.
30. Glowacki G, Braren R, Cetkovic-Cvrlje M, Leiter EH, Haag F, and Koch-Nolte F. Structure, chromosomal localization, and expression of the gene for mouse ecto-mono(ADP- ribosyl)transferase ART5. Gene 275: 267-277, 2001.
31. Glowacki G, Braren R, Firner K, Nissen M, Kuhl M, Reche P, Bazan F, Cetkovic-Cvrlje M, Leiter E, Haag F, and Koch-Nolte F. The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse. Protein Sci 11: 1657-1670, 2002.
32. Graves DJ, Huiatt TW, Zhou H, Huang HY, Sernett SW, Robson RM, and McMahon KK. Regulatory role of arginine-specific mono(ADP-ribosyl)transferase in muscle cells. Adv Exp Med Biol 419: 305-313, 1997.
33. + T lymphocytes induces diabetes in resistant biobreeding/Worcester (BB/W) rats. J Exp Med 166: 461-475, 1987.
34. Gu J and Taniguchi N. Regulation of integrin functions by N-glycans. Glycoconj J 21: 9-15, 2004.
35. Haag F, Freese D, Scheublein F, Ohlrogge W, Adriouch S, Seman M, and Koch-Nolte F. T cells of different developmental stages differ in sensitivity to apoptosis induced by extracellular NAD. Dev Immunol 9: 197-202, 2002.
36. Haag F, Koch-Nolte F, Kuhl M, Lorenzen S, and Thiele HG. Premature stop codons inactivate the RT6 genes of the human and chimpanzee species. J Mol Biol 243: 537-546, 1994.
37. Hamer PW, McGeachie JM, Davies MJ, and Grounds MD. Evans blue dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J Anat 200: 69-79, 2002.
38. Herrero-Yraola A, Bakhit SM, Franke P, Weise C, Schweiger M, Jorcke D, and Ziegler M. Regulation of glutamate dehydrogenase by reversible ADP-ribosylation in mitochondria. EMBO J 20: 2404-2412, 2001.
39. 1 integrin in human and murine muscular dystrophies. J Cell Sci 110: 2873-2881, 1997.
40. Hoffman EP, Brown RH Jr, and Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928, 1987.
41. Hughes PE, Diaz-Gonzalez F, Leong L, Wu C, McDonald JA, Shattil SJ, and Ginsberg MH. Breaking the integrin hinge. A defined structural constraint regulates integrin signaling. J Biol Chem 271: 6571-6574, 1996.
42. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687, 2002.
43. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, and Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696-702, 1992.
44. Jones EM and Baird A. Cell-surface ADP-ribosylation of fibroblast growth factor-2 by an arginine-specific ADP-ribosyltransferase. Biochem J 323: 173-177, 1997.
45. Jorcke D, Ziegler M, Herrero-Yraola A, and Schweiger M. Enzymic, cysteine-specific ADP-ribosylation in bovine liver mitochondria. Biochem J 332: 189-193, 1998.
46. Kato I. Bacterial ADP-ribosylating toxins: molecular structures and signal transducing functions. Microbiol Immunol 35: 349-359, 1991.
47. Kawamura H, Aswad F, Minagawa M, Malone K, Kaslow H, Koch-Nolte F, Schott WH, Leiter EH, and Dennert G. P2X7 receptor-dependent and -independent T cell death is induced by nicotinamide adenine dinucleotide. J Immunol 174: 1971-1979, 2005.
48. Kim UH, Kim MK, Kim JS, Han MK, Park BH, and Kim HR. Purification and characterization of NAD glycohydrolase from rabbit erythrocytes. Arch Biochem Biophys 305: 147-152, 1993.
49. Koch-Nolte F, Haag F, Braren R, Kuhl M, Hoovers J, Balasubramanian S, Bazan F, and Thiele HG. Two novel human members of an emerging mammalian gene family related to mono-ADP-ribosylating bacterial toxins. Genomics 39: 370-376, 1997.
50. Koch F, Haag F, Kashan A, and Thiele HG. Primary structure of rat RT6.2, a nonglycosylated phosphatidylinositol-linked surface marker of postthymic T cells. Proc Natl Acad Sci USA 87: 964-967, 1990.
51. Koch-Nolte F, Petersen D, Balasubramanian S, Haag F, Kahlke D, Willer T, Kastelein R, Bazan F, and Thiele HG. Mouse T cell membrane proteins Rt6-1 and Rt6-2 are arginine/protein mono(ADPribosyl)transferases and share secondary structure motifs with ADP-ribosylating bacterial toxins. J Biol Chem 271: 7686-7693, 1996.
52. Krebs C, Adriouch S, Braasch F, Koestner W, Leiter EH, Seman M, Lund FE, Oppenheimer N, Haag F, and Koch-Nolte F. CD38 controls ADP-ribosyltransferase-2- catalyzed ADP-ribosylation of T cell surface proteins. J Immunol 174: 3298-3305, 2005.
53. Kumar A, Khandelwal N, Malya R, Reid MB, and Boriek AM. Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. FASEB J 18: 102-113, 2004.
54. Larew JS, Peterson JE, and Graves DJ. Determination of the kinetic mechanism of arginine-specific ADP-ribosyltransferases using a high performance liquid chromatographic assay. J Biol Chem 266: 52-57, 1991.
55. Lazarowski ER, Homolya L, Boucher RC, and Harden TK. Direct demonstration of mechanically induced release of cellular DTP and its implication for uridine nucleotide receptor activation. J Biol Chem 272: 24348-24354, 1997.
56. Lesnick ML and Guiney DG. The best defense is a good offense - Salmonella deploys an ADP-ribosylating toxin. Trends Microbiol 9: 2-4, 2001.
57. Li PL, Chen CL, Bortell R, and Campbell WB. 11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle. Circ Res 85: 349-356, 1999.
58. Liddington RC and Ginsberg MH. Integrin activation takes shape. J Cell Biol 158: 833-839, 2002.
59. Liszt G, Ford E, Kurtev M, and Guarente L. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem 280: 21313-21320, 2005.
60. Liu ZX, Azhipa O, Okamoto S, Govindarajan S, and Dennert G. Extracellular nicotinamide adenine dinucleotide induces T cell apoptosis in vivo and in vitro. J Immunol 167: 4942-4947, 2001.
61. Liu ZX, Yu Y, and Dennert G. A cell surface ADP-ribosyltransferase modulates T cell receptor association and signaling. J Biol Chem 274: 17399-17401, 1999.
62. Luo BH, Carman CV, Takagi J, and Springer TA. Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering. Proc Natl Acad Sci USA 102: 3679-3684, 2005.
63. Lupi R, Dani N, Dietrich A, Marchegiani A, Turacchio S, Berrie CP, Moss J, Gierschik P, Corda D, and Di Girolamo M. Endogenous mono-ADP-ribosylation of the free Gβγ prevents stimulation of phosphoinositide 3-kinase-γ and phospholipase C-β2 and is activated by G-protein-coupled receptors. Biochem J 367: 825-832, 2002.
64. McArdle A, Edwards RH, and Jackson MJ. Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse. Muscle Nerve 17: 1378-1384, 1994.
65. McNeil PL and Khakee R. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am J Pathol 140: 1097-1109, 1992.
66. McNeil PL and Kirchhausen T. Opinion: an emergency response team for membrane repair. Nat Rev Mol Cell Biol 6: 499-505, 2005.
67. McNeil PL and Steinhardt RA. Plasma membrane disruption: repair, prevention, adaptation. Annu Rev Cell Dev Biol 19: 697-731, 2003.
68. Menke A and Jockusch H. Extent of shock-induced membrane leakage in human and mouse myotubes depends on dystrophin. J Cell Sci 108: 727-733, 1995.
69. Mueller-Dieckmann C, Ritter H, Haag F, Koch-Nolte F, and Schulz GE. Structure of the ecto-ADP-ribosyl transferase ART2.2 from rat. J Mol Biol 322: 687-696, 2002.
70. Nemoto E, Yu Y, and Dennert G. Cell surface ADP-ribosyltransferase regulates lymphocyte function-associated molecule-1 (LFA-1) function in T cells. J Immunol 157: 3341-3349, 1996.
71. Nguewa PA, Fuertes MA, Valladares B, Alonso C, and Perez JM. Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications. Prog Biophys Mol Biol 88: 143-172, 2005.
72. North RA. Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067, 2002.
73. Okamoto S, Azhipa O, Yu Y, Russo E, and Dennert G. Expression of ADP-ribosyltransferase on normal T lymphocytes and effects of nicotinamide adenine dinucleotide on their function. J Immunol 160: 4190-4198, 1998.
74. Okazaki IJ, Kim HJ, and Moss J. Cloning and characterization of a novel membrane-associated lymphocyte NAD:arginine ADP-ribosyltransferase. J Biol Chem 271: 22052-22057, 1996.
75. Okazaki IJ, Zolkiewska A, Nightingale MS, and Moss J. Immunological and structural conservation of mammalian skeletal muscle glycosylphosphatidylinositol-linked ADP-ribosyltransferases. Biochemistry 33: 12828-12836, 1994.
76. Paone G, Wada A, Stevens LA, Matin A, Hirayama T, Levine RL, and Moss J. ADP-ribosylation of human neutrophil peptide-1 regulates its biological properties. Proc Natl Acad Sci USA 99: 8231-8235, 2002.
77. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, and Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90: 3710-3714, 1993.
78. +:arginine ADP ribosyltransferases with auto-ADP ribosylation activity. J Immunol 156: 4259-4265, 1996.
79. +: a novel autocrine/paracrine signal in osteoblast physiology. Biochem Biophys Res Commun 299: 424-431, 2002.
80. Romanello M, Pani B, Bicego M, and D'Andrea P. Mechanically induced ATP release from human osteoblastic cells. Biochem Biophys Res Commun 289: 1275-1281, 2001.
81. Saxty BA, Yadollahi-Farsani M, Upton PD, Johnstone SR, and MacDermot J. Inactivation of platelet-derived growth factor-BB following modification by ADP-ribosyltransferase. Br J Pharmacol 133: 1219-1226, 2001.
82. Seman M, Adriouch S, Haag F, and Koch-Nolte F. Ecto-ADP- ribosyltransferases (ARTs): emerging actors in cell communication and signaling. Curr Med Chem 11: 857-872, 2004.
83. Seman M, Adriouch S, Scheuplein F, Krebs C, Freese D, Glowacki G, Deterre P, Haag F, and Koch-Nolte F. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19: 571-582, 2003.
84. Shimaoka M, Takagi J, and Springer TA. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct 31: 485-516, 2002.
85. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, and Barnard PJ. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244: 1578-1580, 1989.
86. Smyth LM, Bobalova J, Mendoza MG, Lew C, and Mutafova-Yambolieva VN. Release of β-nicotinamide adenine dinucleotide upon stimulation of postganglionic nerve terminals in blood vessels and urinary bladder. J Biol Chem 279: 48893-48903, 2004.
87. 7 integrin cytoplasmic domains during skeletal muscle development: alternate forms, conformational change, and homologies with serine/threonine kinases and tyrosine phosphatases. J Cell Sci 106: 1139-1152, 1993.
88. Straub V, Rafael JA, Chamberlain JS, and Campbell KP. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 139: 375-385, 1997.
89. 1. Nat Struct Biol 8: 412-416, 2001.
90. Takagi J, Petre BM, Walz T, and Springer TA. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 110: 599-611, 2002.
91. Tanner KG, Landry J, Sternglanz R, and Denu JM. Silent information regulator 2 family of NAD-dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci USA 97: 14178-14182, 2000.
92. Terashima M, Yamamori C, Tsuchiya M, and Shimoyama M. ADP-ribosylation of tubulin by chicken NAD-arginine ADP-ribosyltransferase suppresses microtubule formation. J Nutr Sci Vitaminol (Tokyo) 45: 393-400, 1999.
93. Thiele HG and Haag F. The RT6 system of the rat: developmental, molecular and functional aspects. Immunol Rev 184: 96-108, 2001.
94. Travis MA, Humphries JD, and Humphries MJ. An unraveling tale of how integrins are activated from within. Trends Pharmacol Sci 24: 192-197, 2003.
95. Van Veen AA, van Rijen HV, and Opthof T. Cardiac gap junction channels: modulation of expression and channel properties. Cardiovasc Res 51: 217-229, 2001.
96. 3 "inside-out" activation as regulated by its cytoplasmic face. Cell 110: 587-597, 2002.
97. Von der Mark H, Williams I, Wendler O, Sorokin L, von der Mark K, and Poschl E. Alternative splice variants of α7β1 integrin selectively recognize different laminin isoforms. J Biol Chem 277: 6012-6016, 2002.
98. Wang J, Nemoto E, and Dennert G. Regulation of CTL by ecto-nicotinamide adenine dinucleotide (NAD) involves ADP-ribosylation of a p56lck-associated protein. J Immunol 156: 2819-2827, 1996.
99. 3-subunits. Proc Natl Acad Sci USA 99: 5878-5883, 2002.
100. Xiong YM, Chen J, and Zhang L. Modulation of CD11b/CD18 adhesive activity by its extracellular, membrane-proximal regions. J Immunol 171: 1042-1050, 2003.
101. 3. Science 294: 339-345, 2001.
102. Yadollahi-Farsani M, Kefalas P, Saxty BA, and MacDermot J. Polymorphic forms of human ADP-ribosyltransferase-1 differences in their catalytic activities revealed by labeling of membrane-associated substrates. Eur J Biochem 262: 342-348, 1999.
103. 1 to laminin. Biochem J 385: 309-317, 2005.
104. 7 as substrate for a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase on the surface of skeletal muscle cells. J Biol Chem 268: 25273-25276, 1993.
105. 7 in skeletal muscle myotubes. J Biol Chem 270: 9227-9233, 1995.
106. Zolkiewska A, Nightingale MS, and Moss J. Molecular characterization of NAD:arginine ADP-ribosyltransferase from rabbit skeletal muscle. Proc Natl Acad Sci USA 89: 11352-11356, 1992.